Biological Dynamics, Inc., an innovative diagnostic company committed to improving global health, today announced a supplemental grant to support efforts to optimize and evaluate the performance of a novel TB test currently in development. The funding is from the Bill & Melinda Gates Foundation.
Read MoreBiological Dynamics, Inc., an innovative diagnostic company committed to improving global health outcomes, today announced a new grant award from the Bill & Melinda Gates Foundation.
Read MoreSAN DIEGO--(BUSINESS WIRE)--Today, Biological Dynamics announced it has received a grant from the Bill & Melinda Gates Foundation to help address the pressing need of reducing the burden of tuberculosis (TB) in resource-poor settings.
Read MoreBiological Dynamics is a private molecular diagnostics company located in San Diego. Our proprietary technology offers a novel, fast, and cost-effective lab-on-chip ACE platform that isolates nanoparticles from high conductance physiological solutions.
Our product, the TR(ACE)™ assay, will utilize the platform for monitoring treatment response in oncology. TR(ACE)™ has not been cleared or approved by the U.S. FDA or any foreign regulatory agency.
